« Back
Home /
ETV5 Blocking Peptide (N-term)

ETV5 Blocking Peptide (N-term)

Item no.	ABC-BP19951a
Manufacturer	Abcepta
Amount	500 ug
Category	Oncology Peptides & Proteins Peptides By Organ Bladder Cancer Breast Cancer Gastric Cancer
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Fontaine-Bisson, B., et al. Diabetologia 53(10):2155-2162(2010) Lens, Z., et al. Biochem. Biophys. Res. Commun. 399(1):104-110(2010) Ng, M.C., et al. J. Clin. Endocrinol. Metab. 95(5):2418-2425(2010) Jugessur, A., et al. PLoS ONE 5 (7), E11493 (2010): Elks, C.E., et al. PLoS Med. 7 (5), E1000284 (2010) :
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	ETS translocation variant 5,Ets-related protein ERM,ETV5,ERM
Similar products	ETV5, ERM, ETS translocation variant 5, Ets-related protein ERM
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence is selected from aa 23-37 of HUMAN ETV5
Bio Background	ETV5 binds to DNA sequences containing the consensus nucleotide core sequence GGAA.
Gene Name	ETV5
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP19951a-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 13 days

Compare

Add to wishlist

Get an offer